The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections
Open accessAbstract
COVID-19-associated morbidity and mortality have been attributed to a pathologic host response. Two divergent hypotheses have been proposed: hyperinflammatory cytokine storm; and failure of host protective immunity that results in unrestrained viral dissemination and organ injury. A key explanation for the inability to address this controversy has been the lack of diagnostic tools to evaluate immune function in COVID-19 infections. ELISpot, a highly sensitive, functional immunoassay, was employed in 27 patients with COVID-19, 51 patients with sepsis, 18 critically ill nonseptic (CINS) patients, and 27 healthy control volunteers to evaluate adaptive and innate immune status by quantitating T cell IFN-ɣ and monocyte TFN-α production. Circulating T cell subsets were profoundly reduced in COVID-19 patients. Additionally, stimulated blood mononuclear cells produced less than 40%-50% of the IFN-ɣ and TNF-α observed in septic and CINS patients, consistent with markedly impaired immune effector cell function. Approximately 25% of COVID-19 patients had increased IL-6 levels that were not associated with elevations in other canonical proinflammatory cytokines. Collectively, these findings support the hypothesis that COVID-19 suppresses host functional adaptive and innate immunity. Importantly, IL-7 administered ex vivo restored T cell IFN-ɣ production in COVID-19 patients. Thus, ELISpot may functionally characterize host immunity in COVID-19 and inform prospective therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884 · cited 1×
“Multiple recent studies show that unlike the cytokine storm, which is often considered episodic, lymphopenia is incessant in critically ill COVID-19 patients with and correlates with increased secondary infections and death (11, 13).”
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
COVID-19: consider cytokine storm syndromes and immunosuppression
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa248 · Cited by 4,775
Guo (2020) · doi:10.1186/s40779-020-00240-0 · Cited by 4,735 · cited 1×
“Based on this theory, a number of anti-cytokine and antiinflammatory therapies are being tested in COVID-19, including anti–IL-6(R) antibodies, IL-1 receptor antagonists, and JAK/ STAT inhibitors, with early trial results failing to demonstrate significant efficacy (2, 3, 9, 15–18).”
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
Diao, B., Wang, C., Tan, Y., Chen, X., Liu, Y., Ning, L., Chen, L., Li, M., Liu, Y., Wang, G., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00827 · Cited by 2,475
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study
Wichmann, D., Sperhake, J.-P., Lütgehetmann, M., Steurer, S., Edler, C., Heinemann, A., Heinrich, F., Mushumba, H., Kniep, I., Schröder, A. S., et al. (2020) · Annals of Internal Medicine · doi:10.7326/m20-2003 · Cited by 2,274
Functional exhaustion of antiviral lymphocytes in COVID-19 patients
Zheng, M., Gao, Y., Wang, G., Song, G., Liu, S., Sun, D., Xu, Y., & Tian, Z. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0402-2 · Cited by 1,768 · cited 1×
“6) n 19 17 8 8 10 10 10 10 4 IL-8 Mean (SEM) 118 (21) 327.”
Zhang, C., Wu, Z., Li, J.-W., Zhao, H., & Wang, G.-Q. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105954 · Cited by 1,758
McGonagle, D., Sharif, K., O'Regan, A., & Bridgewood, C. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102537 · Cited by 1,654
COVID-19 cytokine storm: the interplay between inflammation and coagulation
Jose, R. J., & Manuel, A. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30216-2 · Cited by 1,240
Menter, T., Haslbauer, J. D., Nienhold, R., Savic, S., Hopfer, H., Deigendesch, N., Frank, S., Turek, D., Willi, N., Pargger, H., et al. (2020) · Histopathology · doi:10.1111/his.14134 · Cited by 1,230
Waage, A., Brandtzaeg, P., Halstensen, A., Kierulf, P., & Espevik, T. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.1.333 · Cited by 1,173
Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia
Wang, F., Nie, J., Wang, H., Zhao, Q., Xiong, Y., Deng, L., Song, S., Ma, Z., Mo, P., & Zhang, Y. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa150 · Cited by 1,131
Devaux, C. A., Rolain, J.-M., Colson, P., & Raoult, D. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105938 · Cited by 1,099
Xiong, Y., Liu, Y., Cao, L., Wang, D., Guo, M., Jiang, A., Guo, D., Hu, W., Yang, J., Tang, Z., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1747363 · Cited by 1,076
Chen, X., Zhao, B., Qu, Y., Chen, Y., Xiong, J., Feng, Y., Men, D., Huang, Q., Liu, Y., Yang, B., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa449 · Cited by 1,020
Expanding roles for CD4+ T cells in immunity to viruses
Swain, S. L., McKinstry, K. K., & Strutt, T. M. (2012) · Nature Reviews Immunology · doi:10.1038/nri3152 · Cited by 956
Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study
Du, Y., Tu, L., Zhu, P., Mu, M., Wang, R., Yang, P., Wang, X., Hu, C., Ping, R., Hu, P., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202003-0543oc · Cited by 942
Zheng, H.-Y., Zhang, M., Yang, C.-X., Zhang, N., Wang, X.-C., Yang, X.-P., Dong, X.-Q., & Zheng, Y.-T. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0401-3 · Cited by 940
Immunotherapeutic Implications of Il-6 Blockade for Cytokine Storm
Tanaka, T., Narazaki, M., & Kishimoto, T. (2016) · Immunotherapy · doi:10.2217/imt-2016-0020 · Cited by 708
Jamilloux, Y., Henry, T., Belot, A., Viel, S., Fauter, M., El Jammal, T., Walzer, T., François, B., & Sève, P. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102567 · Cited by 658
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19
Wichmann, D. (2020) · Annals of Internal Medicine · doi:10.7326/l20-1206 · Cited by 627
The many faces of the anti-COVID immune response
Vardhana, S. A., & Wolchok, J. D. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20200678 · Cited by 509
Autopsy in suspected COVID-19 cases
Hanley, B., Lucas, S. B., Youd, E., Swift, B., & Osborn, M. (2020) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2020-206522 · Cited by 478
COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?
Sarzi-Puttini, P., Giorgi, V., Sirotti, S., Marotto, D., Ardizzone, S., Rizzardini, G., Antinori, S., & Galli, M. (2020) · Clinical and Experimental Rheumatology · doi:10.55563/clinexprheumatol/xcdary · Cited by 466
Russell, B., Moss, C., George, G., Santaolalla, A., Cope, A., Papa, S., & Van Hemelrijck, M. (2020) · ecancermedicalscience · doi:10.3332/ecancer.2020.1022 · Cited by 439
Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial
Francois, B., Jeannet, R., Daix, T., Walton, A. H., Shotwell, M. S., Unsinger, J., Monneret, G., Rimmelé, T., Blood, T., Morre, M., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.98960 · Cited by 431
Self-citationCOVID-19 Outbreak: An Overview
Ciotti, M., Angeletti, S., Minieri, M., Giovannetti, M., Benvenuto, D., Pascarella, S., Sagnelli, C., Bianchi, M., Bernardini, S., & Ciccozzi, M. (2019) · Chemotherapy · doi:10.1159/000507423 · Cited by 430
IL-7 administration drives T cell–cycle entry and expansion in HIV-1 infection
Sereti, I., Dunham, R. M., Spritzler, J., Aga, E., Proschan, M. A., Medvik, K., Battaglia, C. A., Landay, A. L., Pahwa, S., Fischl, M. A., et al. (2009) · Blood · doi:10.1182/blood-2008-10-186601 · Cited by 342
Convalescent Plasma to Treat COVID-19: Possibilities and Challenges
Roback, J. D., & Guarner, J. (2020) · JAMA · doi:10.1001/jama.2020.4940 · Cited by 299
The 2019 novel coronavirus disease (COVID-19) pandemic: A review of the current evidence
Chatterjee, P., Nagi, N., Agarwal, A., Das, B., Banerjee, S., Sarkar, S., Gupta, N., & Gangakhedkar, R. R. (2020) · Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_519_20 · Cited by 258
Wong, H. R., Cvijanovich, N., Allen, G. L., Lin, R., Anas, N., Meyer, K., Freishtat, R. J., Monaco, M., Odoms, K., Sakthivel, B., et al. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819fcc08 · Cited by 255
Gross examination report of a COVID-19 death autopsy.
Liu, Q., Wang, R., Qu, G., Wang, Y. Y., Liu, P., Zhu, Y. Z., Fei, G., Ren, L., Zhou, Y., & Liu, L. (2020) · PubMed · doi:10.12116/j.issn.1004-5619.2020.01.005 · Cited by 242
Aouba, A., Baldolli, A., Geffray, L., Verdon, R., Bergot, E., Martin-Silva, N., & Justet, A. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217706 · Cited by 228
Oberholzer, A., Souza, S., Tschoeke, S. K., Oberholzer, C., Abouhamze, A. S., Pribble, J. P., & Moldawer, L. L. (2005) · PubMed · Cited by 219
Hospitalization and Critical Care of 109 Decedents with COVID-19 Pneumonia in Wuhan, China
Du, R.-H., Liu, L.-M., Yin, W., Wang, W., Guan, L.-L., Yuan, M.-L., Li, Y.-L., Hu, Y., Li, X.-Y., Sun, B., et al. (2020) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202003-225oc · Cited by 198
Immunotherapies for COVID-19: lessons learned from sepsis
Remy, K. E., Brakenridge, S. C., François, B., Daix, T., Deutschman, C. S., Monneret, G., Jeannet, R., Laterre, P., Hotchkiss, R. S., & Moldawer, L. L. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30217-4 · Cited by 162
Self-citationMatsukura, S., Kokubu, F., Noda, H., Tokunaga, H., & Adachi, M. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)80195-3 · Cited by 160
HiJAKing SARS-CoV-2? The potential role of JAK inhibitors in the management of COVID-19
Spinelli, F. R., Conti, F., & Gadina, M. (2020) · Science Immunology · doi:10.1126/sciimmunol.abc5367 · Cited by 101
Cytokine storm syndrome in severe COVID-19
Ruscitti, P., Berardicurti, O., Iagnocco, A., & Giacomelli, R. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102562 · Cited by 88
Mortality Rate of Infection With COVID-19 in Korea From the Perspective of Underlying Disease
Kang, Y.-J. (2020) · Disaster Medicine and Public Health Preparedness · doi:10.1017/dmp.2020.60 · Cited by 81
Activating Immunity to Fight a Foe — A New Path
Hotchkiss, R. S., & Opal, S. M. (2020) · New England Journal of Medicine · doi:10.1056/nejmcibr1917242 · Cited by 72
Self-citationIL-10 Has Differential Effects on the Innate and Adaptive Immune Systems of Septic Patients
Mazer, M. B., Unsinger, J., Drewry, A. M., Walton, A. H., Osborne, D., Blood, T. M., Hotchkiss, R. S., & Remy, K. E. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900637 · Cited by 61
Self-citationThampy, L. K., Remy, K. E., Walton, A. H., Hong, Z., Liu, K., Liu, R., Yi, V. N., Burnham, C. D., & Hotchkiss, R. S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199497 · Cited by 56
Self-citationMonocyte Function and Clinical Outcomes in Febrile and Afebrile Patients With Severe Sepsis
Drewry, A. M., Ablordeppey, E., Murray, E. T., Dalton, C. M., Fuller, B. M., Kollef, M. H., & Hotchkiss, R. S. (2017) · Shock · doi:10.1097/shk.0000000000001083 · Cited by 30
Self-citationMultiple biomarkers of sepsis identified by novel time-lapse proteomics of patient serum
Hayashi, N., Yamaguchi, S., Rodenburg, F. J., Wong, S. Y., Ujimoto, K., Miki, T., & Iba, T. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222403 · Cited by 30
Sepsis Through the Eyes of Proteomics: The Progress in the Last Decade
Sharma, N. K., & Salomão, R. (2016) · Shock · doi:10.1097/shk.0000000000000698 · Cited by 27
Reply: Calm before the storm: Understanding the role of Janus kinase inhibitors in COVID-19
Peterson, D. M., Damsky, W., & King, B. (2020) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2020.04.097 · Cited by 12
Cited by
Rydyznski Moderbacher, C., Ramirez, S. I., Dan, J. M., Grifoni, A., Hastie, K. M., Weiskopf, D., Belanger, S., Abbott, R. K., Kim, C., Choi, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.038 · Cited by 1,790
“, 2020), polyclonally stimulated T cells (Lucas et al., 2020; Remy et al., 2020), measurements of common leukocyte types, or inflammatory proteins in blood (Giamarellos-Bourboulis et al.”
Immunological considerations for COVID-19 vaccine strategies
Jeyanathan, M., Afkhami, S., Smaill, F., Miller, M. S., Lichty, B. D., & Xing, Z. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-00434-6 · Cited by 1,015
Leisman, D. E., Ronner, L., Pinotti, R., Taylor, M. D., Sinha, P., Calfee, C. S., Hirayama, A. V., Mastroiani, F., Turtle, C. J., Harhay, M. O., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30404-5 · Cited by 855
COVID-19 and the human innate immune system
Schultze, J. L., & Aschenbrenner, A. C. (2021) · Cell · doi:10.1016/j.cell.2021.02.029 · Cited by 714
SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis
Wendisch, D., Dietrich, O., Mari, T., von Stillfried, S., Ibarra, I. L., Mittermaier, M., Mache, C., Chua, R. L., Knoll, R., Timm, S., et al. (2021) · Cell · doi:10.1016/j.cell.2021.11.033 · Cited by 528
Metadata
- Authors
- Remy, K. E., Mazer, M., Striker, D. A., Ellebedy, A. H., Walton, A. H., Unsinger, J., Blood, T. M., Mudd, P. A., Yi, D. J., Mannion, D. A., Osborne, D. F., Martin, R. S., Anand, N. J., Bosanquet, J. P., Blood, J., Drewry, A. M., Caldwell, C. C., Turnbull, I. R., Brakenridge, S. C., Moldwawer, L. L., & Hotchkiss, R. S.
- Venue
- JCI Insight
- Published
- 2020-09-03
- Volume
- 5
- Issue
- 17
- ISSN
- 2379-3708 (ISSN-L)
- OpenAlex
- W3042989521
- Cited by
- 309
- References
- 51
- FWCI
- 7.94
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.